Tao Yao
Wuhan, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 12 publications
Evaluation of serum hepatic enzyme activities in different COVID-19 phenotypes.
Journal: Journal of medical virology
Published: October 03, 2020
Silencing circ-USP1 protects the renal tubular from kidney injury induced by hypoxia via modulating miR-194-5p/DNMT3A axis in acute renal allografts.
Journal: Journal of cellular and molecular medicine
Published: September 16, 2020
Inhibition of lncRNA NEAT1 protects endothelial cells against hypoxia/reoxygenation‑induced NLRP3 inflammasome activation by targeting the miR‑204/BRCC3 axis.
Journal: Molecular medicine reports
Published: February 26, 2020
LncRNA MALAT1 Promotes Oxygen-Glucose Deprivation and Reoxygenation Induced Cardiomyocytes Injury Through Sponging miR-20b to Enhance beclin1-Mediated Autophagy.
Journal: Cardiovascular drugs and therapy
Published: December 12, 2019
Telmisartan attenuates diabetic nephropathy progression by inhibiting the dimerization of angiotensin type-1 receptor and adiponectin receptor-1.
Journal: Life sciences
Published: August 29, 2018
MiR-874 alleviates renal injury and inflammatory response in diabetic nephropathy through targeting toll-like receptor-4.
Journal: Journal of cellular physiology
Published: March 16, 2018
LncRNA MALAT1 sponges miR-203 to promote inflammation in myocardial ischemia-reperfusion injury.
Journal: International journal of cardiology
Published: March 12, 2018
Regulating glioma stem cells by hypoxia through the Notch1 and Oct3/4 signaling pathway.
Journal: Oncology letters
Published: December 23, 2016
Transforming growth factor-β1 in the microenvironment of ischemia reperfusion-injured kidney enhances the chemotaxis of mesenchymal stem cells to stromal cell-derived factor-1 through upregulation of surface chemokine (C-X-C motif) receptor 4.
Journal: Molecular medicine reports
Published: August 08, 2013
Showing 1-12 of 12
Last Updated: 09/26/2026